Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
about
Association of financial status and the quality of life in Chinese women with recurrent ovarian cancerHealth system costs for stage-specific breast cancer: a population-based approach.Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancerPharmacoeconomic considerations in the treatment of breast cancer.Exemestane in the adjuvant treatment of breast cancer in postmenopausal women.Does economic burden influence quality of life in breast cancer survivors?The Economic Burden of Breast Cancer in Iran.Aromatase inhibitors: a safety comparison.Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer.The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France.Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.Incidence-based cost-of-illness model for metastatic breast cancer in the United States.An Exploration of the relative influence of patient's age and cancer recurrence status on symptom distress, anxiety, and depression over time.Patient perceptions of oncologist-patient communication about prognosis: changes from initial diagnosis to cancer recurrence.Cost of care for elderly cancer patients in the United States.
P2860
Q33908900-806EF749-5261-452C-825D-2232AC407155Q34637835-FEFEE475-9CF6-48C8-89FE-B57FC83E703CQ35170200-80049CFC-289E-4C9F-8320-69EFC44974FBQ35205385-5706FEE6-5903-44AB-AA17-E8118107186FQ35440357-E22918D7-87E8-4520-96D9-3F32E98BC858Q35754111-74D5E06F-CD71-4161-8D03-236B003401A5Q36282180-F035A68C-9FB4-445A-ADDC-0069CDD2224DQ36762444-B83A372E-A986-4110-8035-17B28F66F721Q37196398-687490D7-5E8F-4116-B7FA-1AA3D4FCBBEAQ37615072-94A3D112-7ABE-4A9D-941D-40543EA74973Q38321172-A3A7D5FE-EA8C-40E0-86E5-39AC197F4A6FQ42374103-B2A001EE-798D-416B-92C6-FC9CA51B377EQ43626540-2B2AFF31-B0D8-4791-85F5-DF8058934AF3Q43935033-8951B529-A564-4E14-B712-08A0B0F417E8Q44244967-D5692D07-71DC-4A5F-8AA5-FBDCD1D04586Q48495726-E8F07FEA-5E4C-425D-95E5-4A5B133BA470Q50649462-E269DBA5-3C16-4BCE-9289-43D803151D3FQ53730492-FFDF829D-C3D7-4901-A974-CFB31A8BF44B
P2860
Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Economic burden associated wit ...... nalysis of health system data.
@ast
Economic burden associated wit ...... nalysis of health system data.
@en
type
label
Economic burden associated wit ...... nalysis of health system data.
@ast
Economic burden associated wit ...... nalysis of health system data.
@en
prefLabel
Economic burden associated wit ...... nalysis of health system data.
@ast
Economic burden associated wit ...... nalysis of health system data.
@en
P2093
P356
P1433
P1476
Economic burden associated wit ...... nalysis of health system data.
@en
P2093
David Jones
David Nathanson
Lois Lamerato
Sanjay Gandhi
Suzanne Havstad
P304
P356
10.1002/CNCR.21824
P407
P577
2006-05-01T00:00:00Z